Orum Therapeutics to Participate in February Investor Conferences
BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--#ADC--Orum Therapeutics, a biotechnology company pioneering the development of tumor-directed targeted protein degraders, today announced...






